Risk Factors for Tuberculosis in Patients Receiving Tumour Necrosis Factor-α Blockers: What Do We Really Know?

Publisher： Karger

E-ISSN： 1423-0356|90|3|185-186

ISSN： 0025-7931

Source： Respiration, Vol.90, Iss.3, 2015-0, pp. : 185-186

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Factors Affecting the Tuberculosis Risk in Patients Receiving Anti-Tumor Necrosis Factor-α Treatment

By  

Respiration, Vol. 90, Iss. 3, 2015-0 ,pp. : 191-198

Karger

Access to resources Recommend Favorite

HZ risk associated with TNF‐α in RA

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 3, 2015-03 ,pp. : 310-318

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tumour necrosis factor-α polymorphism as one of the complex inherited factors in pemphigus

By Dorota Torzecka Jolanta   Narbutt Joanna   Sysa-jedrzejowska Anna   Borowiec Maciej   Ptasinska Anetta   Woszczek Grzegorz   L. Kowalski Marek  

Mediators of Inflammation, Vol. 12, Iss. 5, 2003-10 ,pp. : 303-307

Informa Healthcare

Access to resources Recommend Favorite

Tumour necrosis factor‐α antagonists as therapies for vitiligo

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 3, 2015-09 ,pp. : 635-635

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tumour necrosis factor‐α antagonists as therapies for vitiligo

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 7-0963, Iss. 3, 2015-09 ,pp. : 635-635

John Wiley & Sons Inc

Access to resources Recommend Favorite